As of 2025-08-06, the Intrinsic Value of Malaysian Genomics Resource Centre Bhd (MGRC.KL) is (206.83) MYR. This MGRC.KL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.20 MYR, the upside of Malaysian Genomics Resource Centre Bhd is -103,515.60%.
The range of the Intrinsic Value is (396.96) - (140.53) MYR
Based on its market price of 0.20 MYR and our intrinsic valuation, Malaysian Genomics Resource Centre Bhd (MGRC.KL) is overvalued by 103,515.60%.
Note: result may not be accurate due to the invalid valuation result of DCF model.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (396.96) - (140.53) | (206.83) | -103515.6% |
| DCF (Growth 10y) | (3,095.71) - (9,359.58) | (4,713.10) | -2356648.4% |
| DCF (EBITDA 5y) | (35.68) - (43.03) | (1,234.50) | -123450.0% |
| DCF (EBITDA 10y) | (852.04) - (1,102.57) | (1,234.50) | -123450.0% |
| Fair Value | -0.13 - -0.13 | -0.13 | -164.34% |
| P/E | (0.31) - (0.46) | (0.32) | -260.2% |
| EV/EBITDA | (0.09) - (0.12) | (0.11) | -153.4% |
| EPV | (0.84) - (1.06) | (0.95) | -574.4% |
| DDM - Stable | (0.30) - (1.13) | (0.71) | -457.5% |
| DDM - Multi | (38.79) - (113.25) | (57.82) | -29011.2% |
| Market Cap (mil) | 27.44 |
| Beta | 0.51 |
| Outstanding shares (mil) | 137.21 |
| Enterprise Value (mil) | 28.51 |
| Market risk premium | 6.85% |
| Cost of Equity | 8.02% |
| Cost of Debt | 7.03% |
| WACC | 7.95% |